Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

MENJUGATE®

(Meningococcal Group C–CRM197 Conjugate Vaccine)

Disclaimer

Original Notice of Compliance (NoC)

April 24, 2001

Therapeutic / Pharmacological Classification

Vaccine for Active Immunization Against Invasive Disease Caused by Neisseria meningitidis Serogroup C

Product Monograph / Prescribing Information / Product Information

Download   Date of Revision: Sep 06, 2006 (1084-a,9,06)
File name: MENJUGATE_1084-a_9_06-E.pdf
File size: 459 KB


This file is presented in PDF format.  This software is available at no charge through the Adobe Web site.  Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.


Menjugate® is a registered trademark of Novartis Vaccines and Diagnostics, Inc.

Printer friendly
Email a friend

This site is for residents of Canada. / This site was updated on December 11th, 2008.